82 related articles for article (PubMed ID: 9144533)
21. Coxsackievirus B3 activates nuclear factor kappa B transcription factor via a phosphatidylinositol-3 kinase/protein kinase B-dependent pathway to improve host cell viability.
Esfandiarei M; Boroomand S; Suarez A; Si X; Rahmani M; McManus B
Cell Microbiol; 2007 Oct; 9(10):2358-71. PubMed ID: 17848167
[TBL] [Abstract][Full Text] [Related]
22. Role of GNRA motif mutations within stem-loop V of internal ribosome entry segment in coxsackievirus B3 molecular attenuation.
M'hadheb-Gharbi MB; El Hiar R; Paulous S; Jaïdane H; Aouni M; Kean KM; Gharbi J
J Mol Microbiol Biotechnol; 2008; 14(4):147-56. PubMed ID: 17693702
[TBL] [Abstract][Full Text] [Related]
23. New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3.
Schmidtke M; Wutzler P; Zieger R; Riabova OB; Makarov VA
Antiviral Res; 2009 Jan; 81(1):56-63. PubMed ID: 18840470
[TBL] [Abstract][Full Text] [Related]
24. Influence of pan-caspase inhibitors on coxsackievirus B3-infected CD19+ B lymphocytes.
Jarasch N; Martin U; Zell R; Wutzler P; Henke A
Apoptosis; 2007 Sep; 12(9):1633-43. PubMed ID: 17520192
[TBL] [Abstract][Full Text] [Related]
25. A whole cell immunization-derived monoclonal antibody that protects cells from coxsackievirus A9 infection binds to both cell surface and virions.
Roivainen M; Alakulppi N; Ylipaasto P; Eskelinen M; Paananen A; Airaksinen A; Hovi T
J Virol Methods; 2005 Dec; 130(1-2):108-16. PubMed ID: 16055201
[TBL] [Abstract][Full Text] [Related]
26. A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells.
Shafren DR; Williams DT; Barry RD
J Virol; 1997 Dec; 71(12):9844-8. PubMed ID: 9371658
[TBL] [Abstract][Full Text] [Related]
27. Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses.
de Verdugo UR; Selinka HC; Huber M; Kramer B; Kellermann J; Hofschneider PH; Kandolf R
J Virol; 1995 Nov; 69(11):6751-7. PubMed ID: 7474086
[TBL] [Abstract][Full Text] [Related]
28. Purification of a HeLa cell receptor protein for group B coxsackieviruses.
Mapoles JE; Krah DL; Crowell RL
J Virol; 1985 Sep; 55(3):560-6. PubMed ID: 2991580
[TBL] [Abstract][Full Text] [Related]
29. Exosomes mediate Coxsackievirus B3 transmission and expand the viral tropism.
Fu Y; Xiong S
PLoS Pathog; 2023 Jan; 19(1):e1011090. PubMed ID: 36634130
[TBL] [Abstract][Full Text] [Related]
30. Attempts to purify a second cellular receptor for a coxsackievirus B3 variant, CB3-RD from HeLa cells.
Mohanty JG; Crowell RL
Virus Res; 1993 Sep; 29(3):305-20. PubMed ID: 8237113
[TBL] [Abstract][Full Text] [Related]
31. Endogenous low-level expression of the coxsackievirus and adenovirus receptor enables coxsackievirus B3 infection of RD cells.
Carson SD; Kim KS; Pirruccello SJ; Tracy S; Chapman NM
J Gen Virol; 2007 Nov; 88(Pt 11):3031-3038. PubMed ID: 17947527
[TBL] [Abstract][Full Text] [Related]
32. Characterization of a YAC-1 mouse cell receptor for group B coxsackieviruses.
Hsu KH; Crowell RL
J Virol; 1989 Jul; 63(7):3105-8. PubMed ID: 2724420
[TBL] [Abstract][Full Text] [Related]
33. HeLa cell heterogeneity and coxsackievirus B3 cytopathic effect: implications for inter-laboratory reproducibility of results.
Carson SD; Pirruccello SJ
J Med Virol; 2013 Apr; 85(4):677-83. PubMed ID: 23408555
[TBL] [Abstract][Full Text] [Related]
34. The crystal structure of a coxsackievirus B3-RD variant and a refined 9-angstrom cryo-electron microscopy reconstruction of the virus complexed with decay-accelerating factor (DAF) provide a new footprint of DAF on the virus surface.
Yoder JD; Cifuente JO; Pan J; Bergelson JM; Hafenstein S
J Virol; 2012 Dec; 86(23):12571-81. PubMed ID: 22973031
[TBL] [Abstract][Full Text] [Related]
35. Properties of the deoxycholate-solubilized HeLa cell plasma membrane receptor for binding group B coxsackieviruses.
Krah DL; Crowell RL
J Virol; 1985 Mar; 53(3):867-70. PubMed ID: 2983096
[TBL] [Abstract][Full Text] [Related]
36. Detection of the human rhinovirus minor group receptor on renaturing Western blots.
Mischak H; Neubauer C; Berger B; Kuechler E; Blaas D
J Gen Virol; 1988 Oct; 69 ( Pt 10)():2653-6. PubMed ID: 2844972
[TBL] [Abstract][Full Text] [Related]
37. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses.
Tomko RP; Xu R; Philipson L
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3352-6. PubMed ID: 9096397
[TBL] [Abstract][Full Text] [Related]
38. Altered receptor specificity of coxsackievirus B3 after growth in rhabdomyosarcoma cells.
Reagan KJ; Goldberg B; Crowell RL
J Virol; 1984 Mar; 49(3):635-40. PubMed ID: 6321753
[TBL] [Abstract][Full Text] [Related]
39. [Susceptibility of some strains of human tumor cells to some viruses of the ECHO group].
Gruia M; Brănescu L; Demetrescu R
Stud Cercet Inframicrobiol; 1966; 17(1):13-22. PubMed ID: 5942913
[No Abstract] [Full Text] [Related]
40. Permissiveness of human embryonal fibroblasts for coxsackieviruses B3. Investigations on virus genetic markers in vitro and localization of virus receptor distribution by immunogold replica technique.
Tonew M; Wagner B; Wagner M; Schmidtke M; Stelzner A
Zentralbl Bakteriol; 1996 Jul; 284(2-3):443-56. PubMed ID: 8837403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
